DK0959899T3 - LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation - Google Patents

LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation

Info

Publication number
DK0959899T3
DK0959899T3 DK96930529T DK96930529T DK0959899T3 DK 0959899 T3 DK0959899 T3 DK 0959899T3 DK 96930529 T DK96930529 T DK 96930529T DK 96930529 T DK96930529 T DK 96930529T DK 0959899 T3 DK0959899 T3 DK 0959899T3
Authority
DK
Denmark
Prior art keywords
inhibit
proliferation
cd2a antibody
cell activation
cd2a
Prior art date
Application number
DK96930529T
Other languages
Danish (da)
English (en)
Inventor
Herve Bazin
Ruth Kaplan
Thomas Kieber-Emmons
Christina E Postema
Mary E White-Scharf
Dominique Latinne
Original Assignee
Biotransplant Inc
Univ Catholique Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotransplant Inc, Univ Catholique Louvain filed Critical Biotransplant Inc
Application granted granted Critical
Publication of DK0959899T3 publication Critical patent/DK0959899T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2806—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96930529T 1996-08-16 1996-08-16 LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation DK0959899T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/013281 WO1998007444A1 (en) 1996-08-16 1996-08-16 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION

Publications (1)

Publication Number Publication Date
DK0959899T3 true DK0959899T3 (da) 2009-09-07

Family

ID=22255617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96930529T DK0959899T3 (da) 1996-08-16 1996-08-16 LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation

Country Status (10)

Country Link
EP (1) EP0959899B9 (de)
JP (1) JP2001521374A (de)
AT (1) ATE432080T1 (de)
AU (1) AU737602B2 (de)
CA (1) CA2262546C (de)
DE (1) DE69637943D1 (de)
DK (1) DK0959899T3 (de)
ES (1) ES2327980T3 (de)
PT (1) PT959899E (de)
WO (1) WO1998007444A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002425A2 (en) * 2002-06-28 2004-01-08 Bio Transplant, Inc. Process for promoting graft acceptance by depletion of hematopoietic stem cells
ES2338111T3 (es) 2002-08-21 2010-05-04 Revivicor, Inc. Animales porcinos que carecen de cualquier expresion de alfa 1,3 galactosiltransferasa funcional.
US7560538B2 (en) 2003-11-05 2009-07-14 University Of Pittsburgh Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region
DK1734814T3 (en) 2004-03-17 2015-04-07 Revivicor Inc Tissue DERIVED FROM ANIMALS IS MISSING ANY EXPRESSION OF FUNCTIONAL ALPHA-1,3 galactosyltransferase
JP2023531251A (ja) * 2020-06-23 2023-07-21 ゼラリオン マルタ リミテッド 抗ｃｄ２抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2700893A (en) 1952-08-06 1955-02-01 Teddy A Kudlacik Balancing device
US4798806A (en) * 1980-01-08 1989-01-17 Ortho Pharmaceutical Corporation Compositions and methods using a monoclonal antibody to a human T cell antigen
GB9125979D0 (en) * 1991-12-06 1992-02-05 Wellcome Found Antibody
EP0687300B1 (de) * 1993-03-05 2001-09-12 Universite Catholique De Louvain Lo-cd2a antikörper und dessen verwendung zur inhibition von t-zell-aktivierung und -wachstum
CN113299700A (zh) 2021-05-08 2021-08-24 武汉华星光电半导体显示技术有限公司 一种显示面板及其制备方法

Also Published As

Publication number Publication date
ATE432080T1 (de) 2009-06-15
EP0959899B1 (de) 2009-05-27
EP0959899B9 (de) 2009-10-21
ES2327980T3 (es) 2009-11-05
EP0959899A4 (de) 2005-01-12
DE69637943D1 (de) 2009-07-09
PT959899E (pt) 2009-08-28
AU6953296A (en) 1998-03-06
WO1998007444A1 (en) 1998-02-26
EP0959899A1 (de) 1999-12-01
CA2262546A1 (en) 1998-02-26
HK1021318A1 (en) 2000-06-09
JP2001521374A (ja) 2001-11-06
AU737602B2 (en) 2001-08-23
CA2262546C (en) 2009-03-17

Similar Documents

Publication Publication Date Title
DK1003552T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DK0741784T3 (da) Ligand (ACT-4-L) til en receptor på overfladen af aktiverede CD4+ T-celler
NO986173L (no) FremgangsmÕte for aktivering av dendrittceller
DE69309472D1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DK0859957T3 (da) Patientspecifikke immunadsorbenser til ekstraporal apherese og fremgangsmåde til deres fremstilling
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
DK0687300T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
DK0610335T3 (da) Fremgangsmåder til udformning af rekombitope peptider
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
DE60042941D1 (de) Verwendung von anti-cd3 monoklonale antikörper und il-5 zur behandlung von autoimmunkrankheiten
NO964200L (no) Behandling av autoimmun sykdom ved anvendelse av oral tolerisering og/eller Th2-forsterkende cytokiner
DE69637943D1 (de) LO-CD2a Antikörper und deren Verwendung zur Hemmung der T-zellen Aktivierung und Proliferation
DK1021196T3 (da) Anvendelse af en kemisk stabiliseret chloritoplösning til inhibering af en antigenspecifik immunreaktion
DK0837672T3 (da) Præparationer og fremgangsmåder til behandling af T-cellemedierede sygdomme
HUT75376A (en) T cell stimulating protein of pestivirus
DE69839943D1 (de) Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
ATE134878T1 (de) Impfstoffe gegen metazoen-parasiten
ATE179331T1 (de) Das durch den monoklonalen menschlichen antikörper 81av78 erkannte antigen ctaa 81av78
DE69333111D1 (de) Natürliche menschliche igm antikörper
ATE99333T1 (de) Immunogen und seine verwendung zur gewinnung von antikoerpern gegen haemoglobin a1c.
RU92008227A (ru) Способ улучшения настроения и самочувствия